Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
REYNDERS MCVEIGH CAPITAL MANAGEMENT LLC | 02-07-2024 | 12-31-2023 | 195 | 1,578,996,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
Enphase Energy Inc | COM | 51 | $6,223,000 | 47,093 | 0.39 | 0.39 | -557 | -1.17 | 12-31-2023 |
Eli Lilly & Co | COM | 52 | $6,008,000 | 10,307 | 0.38 | 0.38 | -100 | -0.96 | 12-31-2023 |
MarketAxess Holdings Inc | COM | 53 | $5,869,000 | 20,041 | 0.37 | 0.36 | -4,538 | -18.46 | 12-31-2023 |
Crispr Therapeutics | NAMEN AKT | 54 | $5,762,000 | 92,048 | 0.36 | 0.24 | 15,870 | 20.83 | 12-31-2023 |